EN
抗体药类似物
Research Grade Labetuzumab
All
TD-HY546016_1.jpg
TD-HY546016_2.jpg
  • CatalogTD-HY546016
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymshMN14,IMMU-130,hMN-14-SN-38,hMN-14-SN-38ADC,hMN14-CL-SN-38,LabetuzumabGovitecan,CAS:219649-07-7
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Labetuzumab


Catalog No. TD-HY546016
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG1-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target Meconium antigen 100, CEACAM5, CEA, CD66e, Carcinoembryonic antigen-related cell adhesion molecule 5, Carcinoembryonic antigen
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P06731
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names hMN14,IMMU-130,hMN-14-SN-38,hMN-14-SN-38ADC,hMN14-CL-SN-38,LabetuzumabGovitecan,CAS:219649-07-7
Background Labetuzumab is a humanised anti-carcinoembryonic antigen (CEA) monoclonal antibody that inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HY546016_1.jpg
Bioactivity
 
Detects Human CD66e/CEA/CEACAM5 in indirect ELISAs.
TD-HY546016_2.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Labetuzumab.